Current Law Journal Content
Washington & Lee Law School
  Current Law Journal Content
                  an index to legal periodicals

  Biotechnology Law Report
  Volume 27, Number 3, June 2008
  homepage                   other issues

  • Paper
  • Benefiting from Biotechnology: Pro-Poor Intellectual Property Rights and Public–Private Partnerships
        Baris Karapinar, Michelangelo Temmerman
        p.189-202                                                                              +cite        

  • Conference Report
  • FDLI's First Annual Conference on Nanotechnology Law, Regulation, and Policy
        M.P. Moon
        p.203-205                                                                              +cite        

  • Regulatory Affairs—Pharmaceutical
  • Bush Administration Asks for Authority to Approve Generic Biologics; U.K. to Require Earlier Release of Adverse Trial Data; FDA Plans More Communication on Drug Risks; FDA Sets Out Rules for Distribution of Papers on Unapproved Uses; Grassley Asks GAO to Probe FDA Approvals; Supreme Court Splits on Rezulin Question; Medical Device Amendments Shield Manufacturers; PDUFA Deadlines Associated with More Approvals of Drugs Found to Have Safety Problems; Bill Barring Genetic Discrimination Passes House; FDA Rejects Advisory Committee Advice, Approves Avastin for Advanced Breast Cancer; Class Certification for Medical Monitoring Denied; Mandated Release of Scientific, Medical Papers Delayed
        p.206-215                                                                              +cite    

  • Regulatory Affairs—Agricultural and Environmental
  • Germany to Allow Planting of One Gene-Altered Crop; Ban on Animals Fed Genetically Modified Crops Causing European Meat Shortage; Reports Laud, Disparage Genetically Engineered Crops
        p.216-217                                                                              +cite    

  • Patents
  • One of Thomson Patents Found Valid by PTO; Cabilly Patent Revoked; FTC Goes After Another Pay-for-Delay Agreement; Earlier Deposit of Biological Materials to Be Required; PTO Disagrees That New Rules on Alternative Language Will Harm Small Businesses and Individual Inventors; No, CAFC Is Not Giving Away Part of Its Jurisdiction over Patents
        p.218-220                                                                              +cite    

  • Patent Litigation
  • CAFC Again Agrees You Can't Save Seed; Judge Blocks Sale of Roche Epo
        p.221-222                                                                              +cite    

  • Financial and Shareholder Affairs
  • Barr Fined Almost $6 Million for Agreement Not to Sell Generic Version of Oral Contraceptive; Maryland Wants to Spend $5 Million to Attract Nanobiotechnology
        p.223-223                                                                              +cite    

  • Scientific Misconduct
  • Reviewer for New England Journal Shares Manuscript with Drug Manufacturer; Chemist Found to Have Plagiarized Data
        p.224                                                                                      +cite    

  • Scientific Developments
  • Interfering RNA Shows Promise in Clinical Trial; HGS Drug Active Against Anthrax; NIH Moving Toward Better Reviews of Grant Applications; New Developments in Medical Nanotechnology; “Three Parent” Human Embryos Created
        p.225-226                                                                              +cite    

  • Bibliography
  • Book Reviews by Arthur Kyriazis, J.D., M.S.E. (Biotechnology); FDA's Scientific Capabilities Criticized; Globalization of Clinical Trials; Resistance to Bt Toxin Found; Hawaii Hopes to Share Profits; Academics, Economists Propose Making Patents Unavailable for Drugs; Review of Molecular Diagnostic Techniques; Who Put Up the Money?
        p.227-243                                                                              +cite    
  • On the Move
        p.244                                                                                      +cite    

  • Texts
  • Oral Arguments: Warner-Lambert Co., LLC, et al. v. Kimberly Kent, et al. (No. 06-1498)
        p.245-255                                                                              +cite    
  • Donna S. Riegel, Individually and as Administrator of the Estate of Charles R. Riegel v. Medtronic, Inc. (No. 06–179)
        p.256-269                                                                              +cite    
  • Draft Guidance for Industry on Good Reprint Practices for the Distribution of Medical Journal Articles and Medical or Scientific Reference Publications on Unapproved New Uses of Approved Drugs and Approved or Cleared Medical Devices; Availability
        p.270-271                                                                              +cite    
  • Wisconsin Alumni Research Foundation v. Xenon Pharmaceuticals, Inc. (2007-1026, -1033)
        p.272                                                                                      +cite    
  • Revision to the Time for Filing of a Biological Deposit and the Date of Availability of a Biological Deposit
        p.273-280                                                                              +cite    
  • Monsanto Company and Monsanto Technology LLC v. Loren David (2007-1104)
        p.281-287                                                                              +cite    
  • Coming Events
        p.288-291                                                                              +cite